tiprankstipranks
Trending News
More News >
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market

Estrella Immunopharma (ESLA) Income Statement

Compare
38 Followers

Estrella Immunopharma Income Statement

Last quarter (Q3 2025), Estrella Immunopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Estrella Immunopharma's net income was $-4.80M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.85M$ 7.31M$ 1.57M$ 1.69M$ 733.69K
Depreciation and Amortization
$ -39.59K$ 0.00$ 228.49K$ 236.56K$ 206.30K
EBITDA
$ -8.85M$ -7.31M$ -686.97K$ -11.16K$ -733.69K
Operating Income
$ -8.85M$ -7.31M$ -1.57M$ -1.69M$ -733.69K
Other Income/Expenses
$ 0.00$ 0.00$ 654.07K$ 1.44M$ 0.00
Pretax Income
$ -8.85M$ -7.31M$ -915.46K$ -1.69M$ -733.69K
Net Income
$ -8.85M$ -7.31M$ -996.10K$ -1.69M$ -733.69K
Per Share Metrics
Basic EPS
$ -0.25$ -0.21$ -0.17$ -0.29$ -0.02
Diluted EPS
$ -0.25$ -0.21$ -0.17$ -0.29$ -0.02
Weighted Average Shares Outstanding
36.68M 35.20M 5.76M 5.85M 35.20M
Weighted Average Shares Outstanding (Diluted)
36.68M 35.20M 5.76M 5.85M 35.20M
Currency in USD

Estrella Immunopharma Earnings and Revenue History